Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 2 Regulatory News (DNA2)

  • There is currently no data for DNA2

Quarterly Report

15 Jul 2021 13:50

RNS Number : 4041F
Doric Nimrod Air Two Limited
15 July 2021
 

15 July 2021

 

DORIC NIMROD AIR TWO LIMITED (the "Company")

(Legal Entity Identifier: 213800ENH57LLS7MEM48)

 

QUARTERLY REPORT

 

To view the Company's Quarterly Report for the period ended 30 June 2021 please follow the link below:

 

http://www.rns-pdf.londonstockexchange.com/rns/4041F_1-2021-7-15.pdf

 

For further information, please contact:

 

Administrative Enquiries:

 

JTC Fund Solutions (Guernsey) Limited

+44 (0) 1481 702 400

 

Shareholder Enquiries:

 

Nimrod Capital LLP

 

Richard Bolchover

Marc Gordon

+44 (0) 207 382 4565

info@nimrodcapital.com

 

 

 

 

END OF ANNOUNCEMENT

 

E&OE - in transmission

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCBDGDRRSBDGBU
Date   Source Headline
21st Jan 20257:00 amRNSCompletion of Compulsory Redemption of Shares
21st Jan 20257:00 amRNSCancellation of Trading on the LSE
16th Jan 202512:06 pmRNSCompulsory Redemption of Shares
23rd Dec 20244:35 pmRNSHolding(s) in Company
12th Dec 20243:47 pmRNSUNAUDITED INTERIM FINANCIAL REPORT
5th Dec 20245:55 pmRNSResult of AGM
2nd Dec 20243:56 pmRNSASSET SALE UPDATE
18th Nov 20243:29 pmRNSNotice of AGM
11th Nov 202412:43 pmRNSASSET SALE UPDATE
5th Nov 20242:17 pmRNSUpdate – Anticipated Redemption of Shares
15th Oct 20244:44 pmRNSQuarterly Fctsheet
15th Oct 20244:42 pmRNSDividend Declaration
15th Oct 20247:00 amRNSAsset Sale Update
2nd Oct 20243:48 pmRNSAsset Sale Update
2nd Sep 20245:26 pmRNSHolding(s) in Company
29th Aug 20243:49 pmRNSHolding(s) in Company
21st Aug 20247:00 amRNSSALE OF REMAINING FIVE ASSETS
24th Jul 20247:00 amRNSAnnual Financial Report
11th Jul 20244:05 pmRNSDividend Declaration
11th Jul 20244:05 pmRNSQuarterly Factsheet
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:04 pmRNSDividend Declaration
11th Jan 20244:19 pmRNSQuarterly Report
11th Jan 20244:18 pmRNSDividend Declaration
22nd Dec 202312:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSCOMPLETION PARTIAL COMPULSORY REDEMPTION & TVR
15th Dec 20232:43 pmRNSUnaudited Interim Financial Report
11th Dec 20237:00 amRNSPartial Compulsory Redemption of Shares
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:45 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
9th Oct 20237:00 amRNSSALE OF TWO ASSETS
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:41 pmRNSAnnual Financial Report
13th Jul 20234:57 pmRNSQuarterly Report
13th Jul 20234:57 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:03 pmRNSQuarterly Report
13th Apr 20235:02 pmRNSDividend Declaration
6th Apr 20235:14 pmRNSMSN 110 REDELIVERY CONDITION
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 202312:56 pmRNSMSN109 REDELIVERY CONDITION
16th Feb 20232:11 pmRNSMSN105, MSN106 and MSN107 Redelivery Condition
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:19 pmRNSDividend Declaration
15th Dec 20225:24 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:08 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.